Structure Therapeutics Inc. - American Depositary Shares (GPCR)

♥ 600 Thanks from members

Structure Therapeutics Inc. (GPCR) displays a polarized market sentiment around its oral GLP-1 asset aleniglipron, balancing strong Phase 3 clinical progression and solid cash reserves against surging cash burn, intense competition, and supply chain/legislative headwinds.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →

Other Nasdaq Tickers

NASDAQ

Direxion Daily AAPL Bear 1X ETF (AAPD)

NASDAQ

Ascentage Pharma Group International - American Depository Shares (AAPG)

NASDAQ

Direxion Daily AAPL Bull 2X ETF (AAPU)

NASDAQ

Superior Group of Companies, Inc. (SGC)

NASDAQ

AbCellera Biologics Inc. - Common Shares (ABCL)

NASDAQ

Alpha Blue Capital US Small-Mid Cap Dynamic ETF (ABCS)

Entity & Market Metadata

Sector: Healthcare Industry: Biotechnology Founder: Benoit Van Hofwegen Founder: Structure Therapeutics Scientific Founders Leadership: Raymond Stevens (CEO) Leadership: Mingchang Pei (CSO) Holder: BVF Partners LP Holder: Sofinnova Investments Holder: General Atlantic GSBR-1290 Oral GLP-1 Receptor Agonist Pipeline #GPCR #Structure Therapeutics #Biotech #GLP-1 Drugs #Obesity Treatment